Catalyst Pharmaceutical Partners Inc buy Bank of America Co.
Start price
09.01.25
/
50%
€23.55
Target price
09.01.26
€29.13
Performance (%)
-12.61%
Price
15.12.25
€20.58
Summary
This prediction is currently active. The price of Catalyst Pharmaceutical Partners Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.61%. This prediction currently runs until 09.01.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Catalyst Pharmaceutical Partners Inc | 3.391% | 3.391% |
| iShares Core DAX® | 0.795% | 1.458% |
| iShares Nasdaq 100 | -3.088% | -0.762% |
| iShares Nikkei 225® | -0.952% | -2.268% |
| iShares S&P 500 | -1.393% | 0.199% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its "buy" rating re-affirmed by analysts at Bank of America Co.. They now have a $30.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€14.95
07.03.24
07.03.24
€21.15
07.03.25
07.03.25
32.99%
08.03.25
08.03.25
